Tryptophan was diminished in mild and critical COVID-19 patients compared to uninfected controls, suggesting a disease-associated activation of tryptophan-consuming indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) that produce the kynurenic acid precursor kynurenine17. The gene discussed is IDO2; the disease is COVID-19.